MDT:NYE-Medtronic plc. (USD)

EQUITY | Medical Devices | New York Stock Exchange

Last Closing

USD 77.61

Change

0.00 (0.00)%

Market Cap

USD 101.99B

Volume

4.37M

Analyst Target

USD 115.83
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Medtronic PLC is engaged in providing medical technology alleviating pain, restoring health, and extending life of people. It currently functions in four operating segments that manufacture and sell device-based medical therapies.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-07 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
ABT Abbott Laboratories

+0.41 (+0.37%)

USD 195.27B
STE STERIS plc

-1.84 (-0.79%)

USD 23.57B
ZBH Zimmer Biomet Holdings Inc

+0.49 (+0.47%)

USD 22.04B
SNN Smith & Nephew SNATS Inc

-0.13 (-0.43%)

USD 13.32B
SNNUF Smith & Nephew plc

N/A

USD 13.18B
GMED Globus Medical

+0.62 (+0.89%)

USD 9.55B
BIO Bio-Rad Laboratories Inc

+6.61 (+1.96%)

USD 9.53B
BIO-B Bio-Rad Laboratories Inc

N/A

USD 9.38B
PEN Penumbra Inc

-0.26 (-0.13%)

USD 7.80B
GKOS Glaukos Corp

+4.18 (+3.30%)

USD 7.05B

ETFs Containing MDT

CIB0:XETRA VanEck Bionic Engineering.. 11.14 % 0.00 %

+0.11 (+0.72%)

USD 6.28M
CYBG:LSE VanEck Bionic Engineering.. 9.75 % 0.00 %

+0.08 (+0.72%)

N/A
UMDV:SW iShares US Medical Device.. 9.28 % 0.00 %

N/A

N/A
FLV American Century ETF Trus.. 5.39 % 0.00 %

+0.37 (+0.72%)

N/A
HHL-U:CA Harvest Healthcare Leader.. 5.10 % 0.00 %

N/A

N/A
HHL-B:CA Harvest Healthcare Leader.. 5.10 % 0.00 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 5.03 % 0.75 %

-0.11 (0.72%)

CAD 0.08B
FHI-B:CA CI Health Care Giants Cov.. 5.03 % 0.00 %

-0.12 (0.72%)

CAD 0.05B
PCIG Litman Gregory Funds Trus.. 4.80 % 0.00 %

+0.07 (+0.72%)

N/A
ABEQ Absolute Core Strategy ET.. 4.55 % 0.00 %

+0.12 (+0.72%)

USD 0.09B
CAMX Cambiar Aggressive Value .. 4.30 % 0.00 %

+0.25 (+0.72%)

USD 0.06B
DIVP The Advisors’ Inner .. 4.03 % 0.00 %

+0.17 (+0.72%)

USD 6.48M
DIVZ Listed Funds Trust - True.. 3.51 % 0.00 %

+0.17 (+0.72%)

USD 0.12B
AIVL WisdomTree Trust - Wisdom.. 3.47 % 0.00 %

+0.61 (+0.72%)

USD 0.41B
DXQ:CA Dynamic Active Enhanced Y.. 2.53 % 0.00 %

+0.24 (+0.72%)

N/A
VSDA VictoryShares Dividend Ac.. 2.47 % 0.35 %

+0.21 (+0.72%)

USD 0.27B
GDVD 2.46 % 0.00 %

N/A

N/A
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.16 % 0.00 %

+0.02 (+0.72%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.16 % 0.00 %

-0.11 (0.72%)

N/A
DVND Touchstone ETF Trust - To.. 2.15 % 0.00 %

+0.20 (+0.72%)

USD 0.03B
TDOC:CA TD Global Healthcare Lead.. 2.12 % 0.00 %

+0.01 (+0.72%)

CAD 0.09B
QUVU 2.03 % 0.00 %

N/A

N/A
PUD.B:CA 1.85 % 0.66 %

N/A

N/A
CUD:CA iShares US Dividend Growe.. 1.70 % 0.66 %

+0.05 (+0.72%)

CAD 0.35B
USDV:SW SPDR® S&P US Dividend Ar.. 1.69 % 0.00 %

+0.32 (+0.72%)

USD 3.90B
REVS Columbia Research Enhance.. 1.45 % 0.00 %

+0.22 (+0.72%)

USD 0.06B
TWAR 1.11 % 0.00 %

N/A

N/A
VIDI Vident International Equi.. 0.62 % 0.63 %

+0.25 (+0.72%)

USD 0.37B
JIGB 0.45 % 0.14 %

N/A

N/A
VCLT Vanguard Long-Term Corpor.. 0.08 % 0.07 %

-0.56 (0.72%)

USD 14.05B
VCSH Vanguard Short-Term Corpo.. 0.08 % 0.07 %

-0.30 (0.72%)

USD 35.74B
SCHZ Schwab U.S. Aggregate Bon.. 0.01 % 0.04 %

-0.34 (0.72%)

USD 8.49B
BLV Vanguard Long-Term Bond I.. 0.00 % 0.07 %

-0.71 (0.72%)

N/A
DTN 0.00 % 0.38 %

N/A

N/A
IHI iShares U.S. Medical Devi.. 0.00 % 0.43 %

+0.23 (+0.72%)

N/A
JDIV 0.00 % 0.12 %

N/A

N/A
AIIQ 0.00 % 0.79 %

N/A

N/A
GDNA 0.00 % 0.00 %

N/A

N/A
INAU 0.00 % 0.00 %

N/A

N/A
HWF:CA 0.00 % 0.00 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

-0.01 (0.72%)

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.01 (0.72%)

N/A
SICK 0.00 % 0.95 %

N/A

N/A
YLD Principal Active High Yie.. 0.00 % 0.65 %

N/A

USD 0.23B
UDVD:LSE SPDR® S&P US Dividend Ar.. 0.00 % 0.00 %

-0.50 (0.72%)

USD 3.76B
USDV:LSE SPDR S&P US Dividend Aris.. 0.00 % 0.00 %

+0.18 (+0.72%)

USD 3.86B
XUKS:LSE db x-trackers FTSE 100 Sh.. 0.00 % 0.00 %

-0.10 (0.72%)

USD 7.23M
SPYD:XETRA SPDR® S&P US Dividend Ar.. 0.00 % 0.00 %

+0.10 (+0.72%)

USD 3.76B
SPPD:XETRA SPDR® S&P US Dividend Ar.. 0.00 % 0.00 %

-0.04 (0.72%)

USD 0.13B
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
SPPD:F SSGA SPDR ETFs Europe I p.. 0.00 % 0.00 %

-0.08 (0.72%)

N/A
DIVS SmartETFs Dividend Builde.. 0.00 % 0.00 %

+0.03 (+0.72%)

USD 0.03B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.79% 55% F 23% F
Dividend Return 1.69% 86% B+ 45% F
Total Return -4.10% 58% F 23% F
Trailing 12 Months  
Capital Gain -9.64% 58% F 18% F
Dividend Return 3.23% 100% F 47% F
Total Return -6.42% 58% F 19% F
Trailing 5 Years  
Capital Gain -21.16% 36% F 26% F
Dividend Return 12.84% 100% F 51% F
Total Return -8.32% 48% F 26% F
Average Annual (5 Year Horizon)  
Capital Gain -4.05% 32% F 21% F
Dividend Return -1.57% 32% F 19% F
Total Return 2.48% 100% F 53% F
Risk Return Profile  
Volatility (Standard Deviation) 18.93% 90% A- 55% F
Risk Adjusted Return -8.29% 32% F 23% F
Market Capitalization 101.99B 91% A- 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Devices) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 31.40 83% 25%
Price/Book Ratio 2.05 63% 42%
Price / Cash Flow Ratio 14.66 52% 26%
Price/Free Cash Flow Ratio 13.84 52% 29%
Management Effectiveness  
Return on Equity 7.26% 72% 46%
Return on Invested Capital 6.09% 64% 49%
Return on Assets 4.43% 76% 68%
Debt to Equity Ratio 47.55% 48% 62%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.